Pricey drugs put squeeze on doctors

Rising prices for cancer drugs are disrupting relationships with patients, causing doctors to go into debt, and threatening to interfere with treatment options. Driving the problem is a new generation of drugs that are transforming cancer care, providing oncologists with the first new options in decades for desperately ill patients. But several months of treatment on these drugs can equal the down payment on a home or a child’s college tuition.